BECN1 and cranioectodermal dysplasia: According to our data, CED treatment results in the activation of autophagy flux through the Akt and MAPK signal pathway, as featured by the reduction of p-Akt, p-mTOR, p-38, and p-Erk1/2 and the accumulation of LC3-II and Beclin1.